Journal details
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
TAYLOR & FRANCIS LTD · ISSN 2169-1401 · eISSN 2169-141X
EISCIEScopusMEDLINEPubMedPMCDOAJ
Overview
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. ISSN 2169-1401 · eISSN 2169-141X. published by TAYLOR & FRANCIS LTD. United States. Biotechnology & Applied Microbiology · Engineering, Biomedical · Materials Science, Biomaterials. impact factor 5.6 (2025). JCR Q1. CAS Zone 2. indexed in EI, SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 30 articles · 2025: 54 articles · 2024: 43 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY?
The impact factor recorded for ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY is 5.6 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY?
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY is listed in CAS Zone 2.
Which databases index ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY?
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY is indexed in EI, SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.